Skip to main content

$1.55 -0.01 (-0.32%)

High

$1.56

Low

$1.52

Trades

1,747

Turnover

$1,891,056

Volume

1,225,647
30 June 2023 at 4:10pm
Register to track PNV and receive email alerts.
Subject
PNV Ann: Annual General Meeting 2021 Webcast Recording

PNV Ann: Q1 FY22 Trading Update - Clarification Announcement

PNV Ann: Results of 2021 Annual General Meeting

PNV Ann: Chairman and Managing Director - AGM address

PNV Ann: COVID Trading Themes - Q1 FY22 Update

PNV Ann: Notice of Annual General Meeting

PNV Ann: First patient enrolled in Pivotal Trial - BARDA

PNV Ann: Chief Operating Officer - Resignation

PNV Ann: Annual Report 2021

PNV Ann: Corporate Governance Statement

PNV Ann: Appendix 4G

PNV Ann: FY21 Results Presentation

PNV Ann: Appendix 4E and FY21 Financial Statements

PNV Ann: Hernia Product Update

PNV Ann: FY21 Results Presentation - Webcast - Amended weblink

PNV Ann: FY21 Results Presentation - Webcast

PNV Ann: FY21 BTM Revenue Results

PNV Ann: Amendment to Managing Directors LTI

PNV Ann: Notification regarding unquoted securities - PNV

PNV Ann: Initial Director's Interest Notice - Andrew Lumsden

PNV Ann: Director Appointment - Andrew Lumsden

PNV Ann: Ceasing to be a substantial holder

PNV Ann: Appointment - Director of Research & Development

PNV Ann: Change of Director's Interest Notice - Bruce Rathie

PNV Ann: PolyNovo signs with Premier Inc. (GPO)

PNV Ann: Director Share Purchase - David Williams

PNV Ann: Director Share Purchase - David Williams

PNV Ann: Cleansing Notice

PNV Ann: Appendix 2A - CFO Exercise of Options Tranche 1

PNV Ann: Chronic wound reimbursement study - first patient recruited

PNV Ann: Distributor App. - PolyNovo enters Denmark, Norway & Iceland

PNV Article: PolyNovo sales growth slows as lockdowns hit surgery rates

PNV Ann: H1 FY21 Results Investor Presentation

PNV Ann: Appendix 4D and H1 FY21 Report

PNV Ann: H1 FY21 Results Webcast

PNV Ann: Chairman David Williams interview with Chris Judd

PNV Ann: PolyNovo enters Italy - Distributor Appointment

PNV Ann: PolyNovo enters Turkey - Distributor Appointment

PNV Ann: PolyNovo enters Poland - Distributor Appointment

PNV Ann: Response to ASX Query

PNV Article: PolyNovo says COVID surge slowed US second quarter sales

PNV Ann: Trading Update - H1 FY21

PNV Ann: Change of Director's Interest Notice - Leon Hoare

PNV Ann: Change of Director's Interest Notice - Paul Brennan

PNV Ann: Change of Director's Interest Notice - Bruce Rathie

PNV Ann: PNV brings Breast Device in-house

PNV Ann: Pivotal Trial IDE Summary

PNV Ann: PolyNovo enters Belgium, Netherlands, Luxemburg & Sweden

PNV Ann: Appendix 3G - COO Options

PNV Ann: Appendix 3Z - Final Director's Interest Notice - M. Johnston

Register to track PNV and receive email alerts.

Similar Companies

ANN
AVR
MGZ
NAN
NXS
OSX
SDI
SDI